Patent US4769331A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4769331A Expired / Lapsed US ⏱️ 0.0 years remaining

Recombinant methods and materials

Assignee: University Patents Inc
•
Filing: 1985-01-09
•
Granted: 1988-09-06
•
Expires: 2005-01-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Specific DNA sequence insertions, deletions and substitutions (i.e., combinations of sequence deletion and insertion) in eukaryotic cell or viral genomes are stably effected through use of selectable DNA sequences comprising a herpesvirus thymidine kinase (tk) gene.

Inventors

  • 👤 Bernard Roizman
  • 👤 Leonard E. Post

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 09:11
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/63; C12N15/79; C12N15/85; C12N15/87; C12N15/90; C12N15/902

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 191 words
A method for stably effecting the insertion or deletion of a selected DNA sequence at a specific site in a viral genome, said method comprising: (1) isolating from said genome a linear DNA fragment comprising both (a) the specific site determined for insertion or deletion of selected DNA sequence and (b) flanking DNA sequences normally preceding and following said site; (2) preparing first and second altered genome fragments from the fragment isolated in step (1). (a) said first altered fragment comprising the fragment comprising a thymidine kinase gene in a position intermediate the ends of said fragment, and (b) said second altered fragment comprising the fragment having said selected DNA sequence inserted therein or deleted therefrom; (3) contacting said genome with said first altered fragment under conditions permitting recombination at sites of DNA sequence homology, selecting for a recombinant genome comprising said thymidine kinase gene, and isolating the recombinant genome; and (4) contacting the recombinant genome isolated in step (3) with said second altered fragment under conditions permitting recombination at sites of DNA sequence homology, selecting for a recombinant genome lacking said thymidine kinase gene, and isolating the recombinant genome product.
Claim 2
Independent Claim 191 words
A method for stably effecting the insertion or deletion of a selected DNA sequence at a specific site in a viral genome, said method comprising: (1) isolating from said genome a linear DNA fragment comprising both (a) the specific site determined for insertion or deletion of selected DNA sequence and (b) flanking DNA sequences normally preceding and following said site; (2) preparing first and second altered genome fragments from the fragment isolated in step (1). (a) said first altered fragment comprising the fragment comprising a thymidine kinase gene in a position intermediate the ends of said fragment, and (b) said second altered fragment comprising the fragment having said selected DNA sequence inserted therein or deleted therefrom; (3) contacting said genome with said first altered fragment under conditions permitting recombination at sites of DNA sequence homology, selecting for a recombinant genome comprising said thymidine kinase gene, and isolating the recombinant genome; and (4) contacting the recombinant genome isolated in step (3) with said second altered fragment under conditions permitting recombination at sites of DNA sequence homology, selecting for a recombinant genome lacking said thymidine kinase gene, and isolating the recombinant genome product.
Claim 3
Dependent Claim 14 words
The method according to claim 1 wherein the genome is a pathogenic viral genome.
Claim 4
Dependent Claim 18 words
The method according to claim 1 wherein said thymidine kinase gene is of human Herpes Virus 1 origin.
Claim 5
Dependent Claim 34 words
The method according to claim 1 wherein the step of selecting for a recombinant genome comprising said thymidine kinase gene comprises the step of exposing the recombinant genome to a growth medium comprising HAT.
Claim 6
Independent Claim 37 words
The method according to claims 1 or 4 wherein the step of selecting for a recombinant genome not comprising said thymidine kinase gene comprises the step of exposing the recombinant genome to a growth medium comprising AraT.
Claim 7
Dependent Claim 31 words
The method according to claim 1 wherein the method comprises the step of deleting one selected DNA sequence and wherein the method comprises the step of inserting another selected DNA sequence.
Claim 8
Dependent Claim 22 words
The method according to claim 6 wherein said deleting and inserting steps are effected at substantially the same site in the genome.
Claim 9
Dependent Claim 20 words
The method according to claim 6 wherein said deleting and inserting steps are effected at different sites in the genome.
Claim 10
Dependent Claim 15 words
The method according to claim 8 wherein the DNA sequences inserted and deleted are identical.

References Cited (Backward Citations)

US4237224A Cited
EP0022685A1 Cited
WO1981002426A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-09-06 1992-03-07 1992-09-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-09-06 1996-03-07 1996-09-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-09-06 2000-03-07 2000-09-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag